Adalimumab/etanerceptOptic neuritis: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2013年 / 1439卷 / 1期

关键词：

D O I：

10.1007/s40278-013-1339-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：5 / 5

相关论文

共 50 条

[41] Adalimumab/methotrexate/mycophenolate-mofetilVarious toxicities: 4 case reports
Reactions Weekly, 2024, 2026 (1) : 21 - 21
[42] Adalimumab/infliximabMycobacterial tuberculosis and systemic lupus erythematosus : 4 case reports
Reactions Weekly, 2022, 1925 (1) : 24 - 24
[43] GolimumabOptic neuritis: 2 case reports
Reactions Weekly, 2017, 1676 (1) : 147 - 147
[44] ImmunotherapiesOptic neuritis: 11 case reports
Reactions Weekly, 2020, 1833 (1) : 206 - 206
[45] Adalimumab/infliximab/ustekinumabMiliary tuberculosis and latent tuberculosis: 4 case reports
Reactions Weekly, 2020, 1797 (1) : 18 - 18
[46] Adalimumab/etanerceptNeutropenia: 5 case reports
Reactions Weekly, 2010, 1311 (1) : 7 - 7
[47] Adalimumab/infliximabHyperhidrosis: 2 case reports
Reactions Weekly, 2016, 1583 (1) : 39 - 39
[48] Adalimumab/etanerceptCancer: 8 case reports
Reactions Weekly, 2010, 1311 (1) : 7 - 7
[49] Adalimumab/infliximabHistoplasmosis: 5 case reports
Reactions Weekly, 2011, 1336 (1) : 5 - 5
[50] Adalimumab/infliximabTuberculosis: 2 case reports
Reactions Weekly, 2021, 1846 (1) : 14 - 14

← 1 2 3 4 5 →